| SC 13D/A | 2023-06-28 | BIOTECHNOLOGY VALUE FUND L P | CTI BIOPHARMA CORP | 0 | 0.0% | EDGAR |
| SC 13G | 2023-04-13 | Stonepine Capital Management, LLC | CTI BIOPHARMA CORP | 7,018,046 | 5.3% | EDGAR |
| SC 13G | 2023-03-24 | LYNCH TIMOTHY P | CTI BIOPHARMA CORP | 6,999,275 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-13 | Stonepine Capital Management, LLC | CTI BIOPHARMA CORP | 4,934,100 | 3.9% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | CTI BIOPHARMA CORP | - | 12.6% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | CTI BIOPHARMA CORP | 7,060,319 | 5.6% | EDGAR |
| SC 13G/A | 2023-01-09 | MILLENNIUM MANAGEMENT LLC | CTI BIOPHARMA CORP | 4,962,769 | 3.9% | EDGAR |
| SC 13G | 2022-10-11 | STATE STREET CORP | CTI BIOPHARMA CORP | - | 12.0% | EDGAR |
| SC 13D/A | 2022-08-11 | BIOTECHNOLOGY VALUE FUND L P | CTI BIOPHARMA CORP | 19,929,130 | 14.4% | EDGAR |
| SC 13D/A | 2022-07-22 | Growth Equity Opportunities V, LLC | CTI BIOPHARMA CORP | - | - | EDGAR |
| SC 13D/A | 2022-06-17 | Growth Equity Opportunities V, LLC | CTI BIOPHARMA CORP | 9,613,101 | 8.8% | EDGAR |
| SC 13G | 2022-06-13 | MILLENNIUM MANAGEMENT LLC | CTI BIOPHARMA CORP | 5,942,285 | 5.5% | EDGAR |
| SC 13G/A | 2022-02-14 | CAXTON CORP | CTI BIOPHARMA CORP | 2,239,300 | 2.3% | EDGAR |
| SC 13G/A | 2022-02-14 | Stonepine Capital Management, LLC | CTI BIOPHARMA CORP | 9,754,935 | 10.0% | EDGAR |
| SC 13G/A | 2021-12-06 | ORBIMED ADVISORS LLC | CTI BIOPHARMA CORP | 4,024,821 | 4.0% | EDGAR |
| SC 13D/A | 2021-03-15 | BIOTECHNOLOGY VALUE FUND L P | CTI BIOPHARMA CORP | 8,605,120 | 10.6% | EDGAR |
| SC 13G/A | 2021-02-16 | CAXTON CORP | CTI BIOPHARMA CORP | 3,749,890 | 5.1% | EDGAR |
| SC 13G/A | 2021-02-12 | Stonepine Capital Management, LLC | CTI BIOPHARMA CORP | 8,148,420 | 10.0% | EDGAR |
| SC 13G | 2020-10-02 | CAXTON CORP | CTI BIOPHARMA CORP | 4,487,317 | 6.1% | EDGAR |
| SC 13D/A | 2020-03-12 | Growth Equity Opportunities V, LLC | CTI BIOPHARMA CORP | 7,384,816 | 10.0% | EDGAR |